Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1364, 2002-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Zoledronic acid to prevent SREs in prostate, renal cancer cost effective
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 578, 2009-01 ,pp. :
Access to resources
Recommend
Zoledronic acid reduces fracture risk . . .
Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. :
Zoledronic acid: durable benefits in skeletal metastases
Inpharma, Vol. 1, Iss. 1455, 2004-01 ,pp. :
Zoledronic acid reduces recurrence risk in women with EBC
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
Zoledronic Acid: A Review of its Use in Breast Cancer
By Lyseng-Williamson Katherine A.
Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. :